SCHEMBL5657006

SCHEMBL5657006

Cc1cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(c3cccc(Br)c3)c3ccccc32)cc(C)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.40
ALDH1A1 P00352 2/20 0.38
CNR1 P21554 2/20 0.38
GPR55 Q9Y2T6 2/20 0.38
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HSD11B1 P28845 1/20 0.34
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
BRD2 P25440 1/20 0.33
DCTPP1 Q9H773 1/20 0.33
ITGB2 P05107 1/20 0.33
ICAM1 P05362 1/20 0.33
ITGAL P20701 1/20 0.33
LMNA P02545 1/20 0.33
XBP1 P17861 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5662233 0.88 HSP90AA1 (0.41) MGLLALDH1A1CNR1GPR55MEN1
SCHEMBL5661596 0.88 CNR1 (0.42) ALDH1A1CNR1GPR55MEN1KMT2A
SCHEMBL30929657 0.88 CNR1 (0.42) ALDH1A1CNR1GPR55MEN1KMT2A
SCHEMBL5660585 0.86 PGR (0.46) MGLLALDH1A1CNR1GPR55MEN1
SCHEMBL5656443 0.85 MAPT (0.44) MGLLALDH1A1CNR1GPR55MEN1
SCHEMBL5659004 0.84 ALDH1A1 (0.38) ALDH1A1CNR1GPR55MEN1KMT2A
SCHEMBL5660687 0.83 AR (0.46) ALDH1A1MEN1KMT2AMAPTTP53
SCHEMBL5659374 0.83 PGR (0.42) ALDH1A1CNR1GPR55MEN1KMT2A
SCHEMBL5658513 0.82 MEN1 (0.43) ALDH1A1CNR1GPR55MEN1KMT2A
SCHEMBL5662112 0.82 MAPT (0.41) MGLLALDH1A1CNR1GPR55MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 MGLL 3012/4885ALDH1A1 723/4885CNR1 362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.